At what age should women discontinue oral contraceptive (OC) pills?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Stop Birth Control Pills in Women

Women should continue using oral contraceptive pills until menopause or age 50-55 years if they wish to prevent pregnancy, as fertility can persist until age 51. 1

Understanding Fertility in Perimenopausal Women

The need for continued contraception in older women is based on several key facts:

  • The median age of menopause is approximately 51 years in North America but can vary from 40 to 60 years 2, 1
  • The median age of definitive loss of natural fertility is 41 years but can range up to age 51 years 2, 1
  • Spontaneous pregnancies, although uncommon, do occur in women over 44 years of age 2, 1
  • No reliable laboratory tests are available to confirm definitive loss of fertility in a woman 2
  • Assessment of follicle-stimulating hormone levels to determine fertility status may not be accurate 2

Risks of Pregnancy vs. Contraception in Older Women

Pregnancy Risks in Advanced Age

Pregnancies in women over 44 years carry significantly higher risks:

  • Maternal complications: hemorrhage, venous thromboembolism, and death 2, 1
  • Fetal complications: spontaneous abortion, stillbirth, and congenital anomalies 2, 1

Contraception Risks in Older Women

The risks associated with continuing contraception must be weighed against pregnancy risks:

  1. Venous Thromboembolism (VTE):

    • Higher incidence in women aged ≥45 years compared to younger users 2, 1
    • Risk is highest in the first year of use (OR: 4.17) and reduces to 2.76 over baseline after 4 years 3
  2. Myocardial Infarction:

    • Higher relative risk among all OC users than non-users 2, 1
    • Risk does not correlate to length of therapy and disappears after treatment termination 3
  3. Stroke:

    • Combined hormonal contraceptives increase risk of thrombotic stroke by 50-100% 4
  4. Breast Cancer:

    • Small but nonsignificant increased relative risks for breast cancer among women who used oral contraceptives when aged ≥40 years 2, 1

Contraceptive Options for Women Over 45

According to U.S. Medical Eligibility Criteria (MEC):

  • Women aged >45 years can safely use (U.S. MEC 1):

    • Progestin-only pills (POPs)
    • Implants
    • Levonorgestrel IUD
    • Copper IUD 2, 1
  • Women aged >45 years generally can use (U.S. MEC 2):

    • Combined hormonal contraceptives
    • DMPA (depot medroxyprogesterone acetate) 2

Risk Factors Requiring Special Consideration

Women should be evaluated for risk factors that might make hormonal contraception unsafe:

  • Smoking: Increases risk of myocardial infarction 10-fold in OC users 3
  • Hypertension: Poorly controlled hypertension increases risk of myocardial infarction and ischemic stroke approximately 3-fold, and hemorrhagic stroke 15-fold 3
  • Multiple cardiovascular risk factors: Consider progestogen-only contraceptives (POCs) which are associated with substantially less risk of cardiovascular events than combined oral contraceptives 3
  • Thrombophilia: Women with factor V Leiden, prothrombin G20210A, or blood group non-O have further increased risk when using hormonal contraception 5

Practical Approach to Discontinuation

  1. Continue contraception until confirmed menopause or age 50-55 years if pregnancy prevention is desired 2, 1
  2. For women with cardiovascular risk factors, consider switching to non-hormonal methods or progestin-only options after age 45 3, 4
  3. If fertility assessment is needed, discontinue OCPs for at least 1-3 months to allow return of normal hypothalamic-pituitary-ovarian function 1

Common Pitfalls to Avoid

  • Stopping contraception too early: Assuming infertility before confirmed menopause can result in unintended pregnancy
  • Ignoring individual risk factors: Cardiovascular risk factors significantly increase the risks associated with combined hormonal contraceptives
  • Failing to consider alternatives: Non-oral hormone therapy appears to have a more favorable risk profile with no increased risk of venous thrombosis 5

Remember that both the American College of Obstetricians and Gynecologists and the North American Menopause Society recommend continuing contraception until menopause or age 50-55 years if pregnancy prevention is desired 2, 1.

References

Guideline

Contraception in Perimenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiovascular risk and the use of oral contraceptives.

Neuro endocrinology letters, 2013

Research

Hormonal contraception, thrombosis and age.

Expert opinion on drug safety, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.